Multicenter Study
. 2019 Dec 1;125(23):4203-4209. doi: 10.1002/cncr.32440. Epub 2019 Sep 3. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes Folasade Fola Popoola May 3 4 , Jesse Nodora 1 2 5 , María Elena Martínez 1 2 5 , Karina Moyano 6 , Shauntay L Davis 7 , Christian B Ramers 1 8 , Felipe Garcia-Bigley 8 , Shawne O'Connell 9 , Kevin Ronan 10 , Melissa Barajas 11 , Sheree Gordon 12 , Giselle Diaz 13 , Evelyn Ceja 14 , Meghan Powers 15 , Elva M Arredondo 16 , Samir Gupta 1 2 17Affiliations
AffiliationsItem in Clipboard
Multicenter Study
Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomesBalambal Bharti et al. Cancer. 2019.
. 2019 Dec 1;125(23):4203-4209. doi: 10.1002/cncr.32440. Epub 2019 Sep 3. Authors Balambal Bharti 1 2 , Folasade Fola Popoola May 3 4 , Jesse Nodora 1 2 5 , María Elena Martínez 1 2 5 , Karina Moyano 6 , Shauntay L Davis 7 , Christian B Ramers 1 8 , Felipe Garcia-Bigley 8 , Shawne O'Connell 9 , Kevin Ronan 10 , Melissa Barajas 11 , Sheree Gordon 12 , Giselle Diaz 13 , Evelyn Ceja 14 , Meghan Powers 15 , Elva M Arredondo 16 , Samir Gupta 1 2 17 AffiliationsItem in Clipboard
AbstractBackground: The effectiveness of colorectal cancer screening with fecal immunochemical tests (FITs) of stool blood depends on high rates of colonoscopy follow-up for abnormal FITs and the use of high-quality tests. This study characterized colonoscopy referral and completion among patients with abnormal FITs and the types of FITs implemented in a sample of Southern California Federally Qualified Health Centers (FQHCs).
Methods: FQHCs in San Diego, Imperial, and Los Angeles Counties were invited to define a cohort of ≥150 consecutive patients with abnormal FITs in 2015-2016 and to provide data on sex, insurance status, diagnostic colonoscopy referrals and completion within 6 months of abnormal FITs, and the types (brands) of FITs implemented. The primary outcomes were the proportions with colonoscopy referrals and completion for all patients at each FQHC and in aggregate.
Results: Eight FQHCs provided data for 1229 patients with abnormal FITs; 46% were male, and 20% were uninsured. Among patients with abnormal FITs, 89% (1091 of 1229; 95% confidence interval [CI], 0.87-0.91) had a colonoscopy referral, and 44% (539 of 1229; 95% CI, 0.41-0.47) had colonoscopy completion. Across FQHCs, the range for colonoscopy referral was 73% to 96%, and the range for completion was 18% to 57%. Six of the 8 FQHCs (75%) reported FIT brands with limited data to support their effectiveness.
Conclusions: In a sample of Southern California FQHCs, diagnostic colonoscopy completion after abnormal FITs was substantially below the nationally recommended benchmark to achieve 80% completion, and the use of FIT brands with limited data to support their effectiveness was high. These findings suggest a need for policies and multilevel interventions to promote diagnostic colonoscopy among individuals with abnormal FITs and the use of higher quality FITs.
Keywords: Federally Qualified Health Center; Hispanic; abnormal fecal immunochemical test (FIT); colorectal cancer; screening.
© 2019 American Cancer Society.
Conflict of interest statementConflict of Interest Statement
The Authors have no relevant conflicts of interest to disclose.
FiguresFigure 1:. Study flow and overall summary…
Figure 1:. Study flow and overall summary of colonoscopy referral and completion in a sample…
Figure 1:. Study flow and overall summary of colonoscopy referral and completion in a sample of Federally Qualified Health Centers in San Diego, Imperial and Los Angeles Counties of California; Jan 2015-June 2016; N= 1229.The process for sample selection, and overall summary rate of colonoscopy referral and completion at included Federally Qualified Health Centers is depicted.
Figure 2:. Diagnostic colonoscopy referral and completion…
Figure 2:. Diagnostic colonoscopy referral and completion rates after abnormal FIT across a sample of…
Figure 2:. Diagnostic colonoscopy referral and completion rates after abnormal FIT across a sample of 8 Federally Qualified Health Centers in San Diego, Imperial and Los Angeles Counties of California; Jan 2015-June 2016; N= 1229.Proportion of patients with abnormal FIT with colonoscopy referral and colonoscopy completion are depicted for each included FQHC. FIT, fecal immunochemical test; FQHC, Federally Qualified Health Center.
Similar articlesEscaron AL, Garcia J, Petrik AF, Ruiz E, Nyongesa DB, Thompson JH, Coronado GD. Escaron AL, et al. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221138423. doi: 10.1177/21501319221138423. J Prim Care Community Health. 2022. PMID: 36448466 Free PMC article.
Issaka RB, Bell-Brown A, Snyder C, Atkins DL, Chew L, Weiner BJ, Strate L, Inadomi JM, Ramsey SD. Issaka RB, et al. JAMA Netw Open. 2021 Aug 2;4(8):e2120159. doi: 10.1001/jamanetworkopen.2021.20159. JAMA Netw Open. 2021. PMID: 34374771 Free PMC article.
Gies A, Gruner LF, Schrotz-King P, Brenner H. Gies A, et al. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1829-1839.e4. doi: 10.1016/j.cgh.2019.03.001. Epub 2019 Mar 6. Clin Gastroenterol Hepatol. 2019. PMID: 30851476
Meklin J, Syrjänen K, Eskelinen M. Meklin J, et al. Anticancer Res. 2020 Feb;40(2):575-581. doi: 10.21873/anticanres.13987. Anticancer Res. 2020. PMID: 32014898 Review.
Niedermaier T, Weigl K, Hoffmeister M, Brenner H. Niedermaier T, et al. Eur J Epidemiol. 2017 Jun;32(6):481-493. doi: 10.1007/s10654-017-0279-2. Epub 2017 Jun 30. Eur J Epidemiol. 2017. PMID: 28667446 Review.
Ferrari RM, Leeman J, Brenner AT, Correa SY, Malo TL, Moore AA, O'Leary MC, Randolph CM, Ratner S, Frerichs L, Farr D, Crockett SD, Wheeler SB, Lich KH, Beasley E, Hogsed M, Bland A, Richardson C, Newcomer M, Reuland DS. Ferrari RM, et al. Implement Sci Commun. 2023 Sep 20;4(1):118. doi: 10.1186/s43058-023-00485-5. Implement Sci Commun. 2023. PMID: 37730659 Free PMC article.
Wang C, Shaukat A. Wang C, et al. Gastroenterol Hepatol (N Y). 2025 Mar;21(3):163-171. Gastroenterol Hepatol (N Y). 2025. PMID: 40115656 Free PMC article.
Nodora JN, Gupta S, Howard N, Motadel K, Propst T, Rodriguez J, Schultz J, Velasquez S, Castañeda SF, Rabin B, Martínez ME. Nodora JN, et al. J Natl Cancer Inst. 2021 Aug 2;113(8):962-968. doi: 10.1093/jnci/djaa117. J Natl Cancer Inst. 2021. PMID: 32780851 Free PMC article.
Coronado GD, Johnson ES, Leo MC, Schneider JL, Smith D, Mummadi R, Petrik AF, Thompson JH, Jimenez R. Coronado GD, et al. Contemp Clin Trials. 2020 Feb;89:105920. doi: 10.1016/j.cct.2019.105920. Epub 2019 Dec 24. Contemp Clin Trials. 2020. PMID: 31881390 Free PMC article.
Gautom P, Rosales AG, Petrik AF, Thompson JH, Slaughter MT, Mosso L, Hussain SA, Jimenez R, Coronado GD. Gautom P, et al. Cancer Prev Res (Phila). 2024 Jul 2;17(7):325-333. doi: 10.1158/1940-6207.CAPR-23-0498. Cancer Prev Res (Phila). 2024. PMID: 38641422 Free PMC article. Clinical Trial.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3